Introduction {#sec1}
============

The pyrazole scaffold is one of the most prevalent and important scaffolds in medicinal chemistry. Many pyrazoles have been shown to exhibit a wide range of biological activities such as antimicrobial, anticonvulsant, anti-inflammatory, antifungal, antiviral, and anticancer activity, to name just a few.^[@ref1]^ Several pyrazole-containing compounds are commercial drugs such as sildenafil and celecoxib.^[@ref1]^ Pyrazoles have been also used as ligands for transition-metal-catalyzed cross-coupling reactions.^[@ref2]^

Among the many pyrazoles that exhibit biological activity are 3,5-diarylpyrazoles.^[@ref1]^ Various procedures have been developed to prepare these compounds.^[@ref1],[@ref3]^ However, many of these procedures use expensive or hazardous transition-metal catalysts^[@ref4]^ or undesirable solvents,^[@ref4]^ or stoichiometric or excess amounts of harsh or hazardous reagents (LiHMDS, *t*BuOLi, *t*BuOK, *n*-BuLi),^[@ref5]^ or require the preparation of substituted chalcones,^[@ref6]^ or specialized reagents,^[@ref7]^ or the preparation or formation of potentially dangerous diazo or azido substrates or intermediates.^[@ref8]^ Here, we report that 3,5-diarylpyrazoles can be prepared in good yield by reacting substituted acetophenones or aryl aldehydes with the hydrazones of aromatic aldehydes or acetophenones in the presence of catalytic amounts of I~2~ and/or acid and a modest excess of dimethyl sulfoxide (DMSO) in ethanol.

Results and Discussion {#sec2}
======================

We initiated our studies by determining whether 3,5-diarylpyrazoles could be formed by reacting substituted 2′-bromoacetophenones with aryl hydrazones using 2′-bromoacetophenone (**1**) benzalhydrazone (**2**) as model substrates. We anticipated that if the reaction between **1** and **2** occurred preferentially at the carbonyl of **1**, then the resulting intermediate **I** would undergo further reaction (vide infra) to produce the desired 3,5-diarylpyrazole **3** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).

![Formation of Pyrazole **3** via Intermediate **I**](ao-2018-02304m_0001){#sch1}

A mixture of 1 equiv of **1** and 1.2 equiv of **2** in EtOH was stirred at room temperature for 5 min and then refluxed. The starting bromoacetophenone is completely consumed after 15--25 min as judged by thin-layer chromatography (TLC). After 30 min reflux, the mixture was subjected to workup and chromatography, which provided pyrazole **3** in a 30% yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). Longer reaction times did not give better yields. The structure of **3** was confirmed by X-ray crystallography (see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b02304/suppl_file/ao8b02304_si_001.cif)). Increasing the number of equiv of **2** to 1.4 or 2.2 gave only modest increases in yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 2 and 3). However, when 1.4 equiv of **2** was added to a solution of **1** in the refluxing ethanol and the reflux continued for 0.5 h, the yield of **3** increased to 92% ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 4). Reducing the equiv of **2** to 1.2 equiv resulted in a decrease in the yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 5). Applying these conditions using 4′-methoxy-2-bromoacetophenone (**4**) produced pyrazole **5** in 86% yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 6). 2-Phenoxyacetophenone (**5**) failed to undergo reaction with hydrazone **2** to give pyrazole **3** under these conditions ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 7).

###### Optimization of Pyrazole Formation Using Phenacyl Derivatives and Benzal Hydrazone

![](ao-2018-02304m_0004){#fx1}

  entry   phenacyl derivative   equiv **2**   time (h)                              yield[c](#t1fn3){ref-type="table-fn"} (%)
  ------- --------------------- ------------- ------------------------------------- -------------------------------------------
  1       **1**                 1.2           0.5[a](#t1fn1){ref-type="table-fn"}   30
  2       **1**                 2.2           0.5[a](#t1fn1){ref-type="table-fn"}   39
  3       **1**                 1.4           0.5[a](#t1fn1){ref-type="table-fn"}   39
  4       **1**                 1.4           0.5[b](#t1fn2){ref-type="table-fn"}   92
  5       **1**                 1.2           0.5[b](#t1fn2){ref-type="table-fn"}   80
  6       **4**                 1.4           0.5[b](#t1fn2){ref-type="table-fn"}   86
  7       **5**                 1.4           48                                    NR[d](#t1fn4){ref-type="table-fn"}

Compound **2** was added to a solution of phenacyl derivative at room temperature and then the reaction mixture was refluxed.

Compound **2** was added to a refluxing solution of phenacyl derivative.

Isolated yield.

No reaction.

Benzal hydrazone can potentially attack phenacyl bromides at the carbonyl carbon to give intermediate I (pathway a, [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}) or at the α-position to give intermediate IV (pathway b, [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). Busch et al. reported that the reaction of bromoacetophenone with excess hydrazine hydrate in ethanol at −5 °C occurs at the α-position to give 2-hydrazinyl-1-phenylethan-1-one in 60% yield.^[@ref9]^ However, pathway b does not occur under our conditions as this route would produce 3,4-disubstituted pyrazoles that were not isolated from the reactions. We propose two possible pathways, c and d, for 3,5-diarylpyrazole formation. In pathway c, intermediate I tautomerizes/aromatizes to intermediate II, which then cyclizes to give intermediate III. Elimination of HBr from intermediate III gives the 3,5-disubstituted pyrazoles. In pathway d, intermediate I loses Br^--^ to form resonance stabilized cation V, which can cyclize to give intermediate VI. Deprotonation of VI gives intermediate VII, which upon tautomerization/aromatization yields the 3,5-disubstituted pyrazoles.

![Proposed Mechanisms for the Formation of 3,5-Disubstituted Pyrazoles from Phenacyl Bromides and Benzal Hydrazone](ao-2018-02304m_0002){#sch2}

To make the procedure more broadly applicable, we decided to use ketones instead of phenacyl bromides and generate the haloketone in situ using iodine. Refluxing a mixture of 2.0 equiv **2**, 1.0 equiv of acetophenone, and 1.0 equiv of iodine in ethanol at a reflux for 1.5 h afforded **3** in 80% yield ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 1). Decreasing the number of equivalents of benzalhydrazone to 1.5 or 1.2 resulted in a decrease in yield ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 2 and 3). Decreasing the amount of iodine to 0.1 equiv resulted in only a trace amount of **3** ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 4).

###### Optimization of the Reaction of Acetophenone (**7**) with Hydrazone **2** for the Production of Pyrazole **3**

![](ao-2018-02304m_0005){#fx2}

  entry   equiv **2**   I~2~ (equiv)   DMSO[b](#t2fn2){ref-type="table-fn"}   HCl[c](#t2fn3){ref-type="table-fn"}   H~2~SO~4~[e](#t2fn5){ref-type="table-fn"}   time (h)   yield[a](#t2fn1){ref-type="table-fn"} (%)
  ------- ------------- -------------- -------------------------------------- ------------------------------------- ------------------------------------------- ---------- -------------------------------------------
  1       2.0           1.0                                                                                                                                     1.5        80
  2       1.5           1.0                                                                                                                                     1.5        76
  3       1.2           1.0                                                                                                                                     1.5        45
  4       2.0           0.1                                                                                                                                     24         trace
  5       1.5           0.1            DMSO                                                                                                                     24         trace
  6       1.5           0.1            DMSO                                   used                                                                              5          85
  7       1.2           0.1            DMSO                                   used                                                                              5          85
  8       1.2           0.05           DMSO                                   used                                                                              8          85
  9       1.2           0.1            DMSO[d](#t2fn4){ref-type="table-fn"}   used                                                                              4          85
  10      1.2                          DMSO                                   used                                                                              48         81
  11      1.2                          DMSO                                                                         used                                        5          0
  12      1.2                          DMSO                                   used                                  used                                        5          83
  13      1.2                          DMSO                                                                                                                     24         0

Isolated yield.

Three equivalents of DMSO added unless stated otherwise.

75 μL of HCl was used per 1.5 mmol of ketone.

Four equivalents of DMSO added.

Catalytic amounts of H~2~SO~4~ is used (25 μL per 1.5 mmol of ketone).

While this work was in progress, Aegurla and Peddinti reported the synthesis of 3,5-diarylpyrazoles using a process very similar to that described above wherein aryl hydrazones, generated in situ, were reacted with substituted acetophenones in the presence of 1 equiv of I~2~ in EtOH at 70 °C for 12 h.^[@ref10]^ They also showed that the reaction of α-iodoacetophenone with aryl hydrazones in refluxing EtOH at 70 °C provided 3,5-diarylpyrazoles. They proposed that both reactions proceeded via an intermediate similar to I ([Schemes [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"} and [[2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}, I in place of Br) and pathway d, though, in our opinion, pathway c is also possible.

Inspired by the successful synthesis of **3** from phenacyl halides and aryl hydrazones (possibly via route c, [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}), we investigated whether pyrazole **3** could be prepared via the route outlined in [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}. We reasoned that the reaction of acetophenone (**7**) with hydrazone **2** may result in the reversible formation of pyrazoline intermediate X via intermediates VIII and IX, which, in the presence of an oxidant, would be irreversibly oxidized to pyrazole **3**.

![Proposed Alternative Route to Pyrazole **3**](ao-2018-02304m_0003){#sch3}

As DMSO/I~2~ is a well-known green catalyst for iodine-mediated oxidations,^[@ref11],[@ref12]^ including the oxidation of pyrazolines to pyrazoles,^[@ref13]^ we first explored the route outlined in [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"} using these reagents. However, performing the reaction using 0.1 equiv I~2~ and 3.0 equiv DMSO resulted in only trace amounts of the desired product after 24 h reflux and much of the starting materials remained unconsumed ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 5). Therefore, this reaction was repeated except a cat. amount of HCl was added, which we anticipated would promote the formation of imine VIII and cyclization of intermediate IX. Under these conditions, pyrazole **3** was obtained in an 85% yield after 5 h reflux ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 6). Decreasing the amount of iodine to 0.05 equiv or increasing the amount of DMSO to 4.0 equiv resulted respectively in increasing or decreasing of the reaction time ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 7--9). As DMSO/HCl is also a known oxidant,^[@ref14]^ we attempted the reaction in the absence of I~2~ but with a cat. amount of HCl. Under these conditions, pyrazole **3** was formed in an 81% yield, but the reaction took 48 h ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 10). Increasing the amount of cat. HCl by 2- or 3-fold did not result in an increase in yield or reaction time. The combination of DMSO and cat. H~2~SO~4~ ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 11) did not result in the formation any pyrazole after 5 h; however, when performing the reaction in the presence of both cat. HCl and cat. H~2~SO~4~, the reaction was complete within 5 h and pyrazole **3** was obtained in 83% yield ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 12). No pyrazole product was formed when the reaction was performed with just DMSO (no I~2~ or acid, [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 13).

We prepared a series of pyrazoles (**3**, **16**--**25**) by reacting acetophenones (**7**--**12**) with aryl hydrazones (**2**, **13**--**15**) in refluxing EtOH and in the presence of either cat. HCl/4 equiv DMSO/cat. I~2~ (method A), cat. HCl/4 equiv DMSO (method B), or, to a lesser extent, cat. HCl/cat. H~2~SO~4~/4 equiv DMSO (method C) ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Method A provided the pyrazoles in good to excellent yield usually within 10--16 h. The exception was the 4-amino derivative **19**, which did not give any pyrazole product. Acetophenones bearing electron-donating groups tended to take longer to react than acetophenone (i.e., entries 1--3 versus entries 4--6). Method B also gave the pyrazoles in good yield, though, as expected, the reaction times were longer than with method A. Method C was examined for the preparation of pyrazoles **3**, **16**, **18**, and **19** (entries 4, 7, and 10). This method was successful in all four cases, though the yields were slightly lower compared to method A and the purification more challenging.

###### Synthesis of 3,5-Disubstituted Pyrazoles from Aryl Ketones and Aldehyde Hydrazones

![](ao-2018-02304m_0006){#fx3}

Method A: Ketone added to 1.2 equiv of the aldehyde hydrazone in ethanol followed by cat. aq HCl. Reflux for 1 h and then add 4 equiv DMSO and 10 mol % I~2~.

Method B: Same as method A, except no I~2~ added.

Method C: Same as method B, except cat. HCl and cat. H~2~SO~4~ added at the beginning.

Isolated yield.

We also attempted to prepare 3,5-diaryl-4-aryloxypyrazoles by reacting 2-phenoxyacetophenone (**5**) with aryl hydrazones using methods A or B; however, this did not afford 4-aryloxypyrazoles, but rather the 4-unsubstituted pyrazoles ([Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}). We later found that the reaction does not require DMSO or I~2~ to proceed and requires just cat. HCl (entry 5), suggesting that the reaction proceeds in a manner similar to when using bromoacetophenone. The HCl probably helps promote the formation of intermediate I ([Schemes [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"} or [[2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}, where Br is replaced with OPh) and may also aid in the loss of PhOH by acting as general acid. The fact that the reaction of hydrazone **2** with 2-phenoxyacetophenone in the absence of added acid did not produce pyrazole **3** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 7) indicates that the presence of acid is essential for pyrazole formation when using 2-phenoxyacetophenone as one of the substrates. In the case of the reaction of hydrazone **2** with 2-bromoacetophenone (**1**) (i.e., [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 4), no exogenous acid was required for pyrazole formation. This may be due to the formation of HBr during the reaction, which helps promote the formation of intermediate I.

The reverse approach, using ketone hydrazones (**26** and **27**) and benzaldehydes (**28**--**32**), also provided pyrazoles in good yield ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}). Pyrazoles can be prepared in very good yield using either approach or either methodology A or B, as evidenced by the synthesis of pyrazoles **20**, **22**, and **23** ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, entries 13 and 14 and 17--20 and [Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, entries 1 and 6--9).

###### Synthesis of 3,5-Diarylpyrazoles Using Ketone Hydrazones and Aryl Aldehydes

![](ao-2018-02304m_0007){#fx4}

Method A: Ketone added to 1.2 equiv of the aldehyde hydrazone in ethanol followed by cat. aq HCl. Reflux for 1 h and then add 4 equiv DMSO and 10 mol % I~2~.

Method B: Same as method A, except no I~2~ added.

Isolated yield.

Conclusions {#sec3}
===========

In summary, we have developed a method for preparing 3,5-diarylpyrazoles in good to excellent yields by reacting aryl or ketone hydrazones with acetophenones or aryl aldehydes in EtOH and using only catalytic amounts of I~2~ or acid and a modest excess of DMSO to promote the reaction. The substrates are readily available or easily prepared and the reagents common and very inexpensive. 3,5-Diarylpyrazoles were also obtained in good yield by reacting 2-bromoacetophenones or 2-phenoxyacetophone/cat. HCl with aryl hydrazones. We are now employing these procedures to prepare libraries of 3,5-diarylpyrazoles, which will be examined as potential anticancer agents.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

All reagents, ketones, aldehydes, and solvents were purchased from commercial suppliers and used without purification unless stated otherwise. Hydrazones **2**,^[@ref15]^**13**,^[@ref16]^**14**,^[@ref17]^**15**,^[@ref18]^ and **27**([@ref19]) were prepared using literature procedures.

Chemical shifts (δ) for ^1^H NMR spectra run in DMSO-*d*~6~ are reported in parts per million (ppm) relative to DMSO residual solvent protons (δ 2.5). Chemical shifts for ^13^C NMR spectra run in DMSO-*d*~6~ are reported in ppm relative to the solvent residual carbon (δ 39.5). Chemical shifts (δ) for ^1^H NMR spectra run in acetone-*d*~6~ are reported in ppm relative to DMSO residual solvent protons (δ 2.05). Chemical shifts for ^13^C NMR spectra run in DMSO-*d*~6~ are reported in ppm relative to the solvent residual carbon (δ 30.8). Peaks in NMR spectra are described as follows: singlet (s), broad singlet (bs), doublet (d), triplet (t), apparent doublet (appd), apparent triplet (appt), and doublet of doublets (dd). Samples for high-resolution positive-ion electrospray ionization mass spectrometry (HRMS-ESI^+^) were prepared in 1:1 CH~3~CN/H~2~O + 0.2% formic acid.

### Synthesis of \[1-(3,4-Dimethoxy-phenyl)-ethylidene\]-hydrazine (**26**) {#sec4.1.1}

3,4-Dimethoxyacetophenone (0.02 mol, 3.6 g, 1.0 equiv) was added to a stirred solution of 80% hydrazine hydrate (0.12 mol, 7 mL, 6.0 equiv) in ethanol (20 mL). A catalytic amount of acetic acid (ca. 0.25 mL) was added, and the mixture was stirred at room temperature for 5 min and then refluxed for 3 h. After stirring at room temperature overnight, the mixture was concentrated by rotary evaporation, diluted with water, and the pH adjusted to 4--5 using 6 N HCl. The formed precipitate was filtered, washed with water, and dried. ^1^H NMR (CDCl~3~, 300 MHz): δ 7.63 (d, *J* = 1.7 Hz, 1H), 7.33 (dd, *J* = 1.8, 8.3 Hz, 1H), 6.86 (d, *J* = 8.3 Hz, 1H), 3.93 (s, 3H), 3.90 (s, 3H), 2.28 (s, 3H); ^13^C NMR (CDCl~3~, 72 MHz): 157.1, 150.5, 148.8, 131.4, 119.8, 110.2, 109.0, 55.9, 14.8.

General Procedure for the Synthesis of Pyrazoles from Phenacyl Bromides and Benzal Hydrazone {#sec4.2}
--------------------------------------------------------------------------------------------

A solution of phenacyl bromide (1.5 mmol, 1.0 equiv) in ethanol (10 mL) was heated to reflux and then benzal hydrazone (2.1 mmol, 252 mg, 1.4 equiv) was added. The mixture was refluxed for 30 min, cooled, diluted with water, and extracted with EtOAc (3 × 20 mL). The combined EtOAc extracts were washed with water (1 × 20 mL), dried over anhydrous magnesium sulfate, concentrated by rotary evaporation, and purified by column chromatography or crystallization.

### 3,5-Diphenylpyrazole (**3**) {#sec4.2.1}

Pale yellow solid. Crystals for X-ray diffraction studies were obtained by crystallization in 20% EtOAc--hexane, 304 mg, 92%, mp 201--203 °C (lit.:^[@ref19]^ 202--204 °C). ^1^H NMR (DMSO-*d*~6~, 500 MHz): δ 13.41 (s, 1H), 7.89 (bs, 2H), 7.84 (bs, 2H), 7.45 (bs, 4H), 7.33 (bs, 2H), 7.19 (s, 1H). ^13^C NMR (DMSO-*d*~6~, 120 MHz): δ 151.4, 143.3, 133.5, 128.8, 128.0, 127.4, 125.0; HRMS-ESI^+^ (*m*/*z*) calcd for C~15~H~13~N~2~ (M + 1H)^+^, 221.1073; found 221.1072.

### 3-(4-Methoxyphenyl)-5-phenyl-1*H*-pyrazole (**6**) {#sec4.2.2}

Purified by column chromatography using 30% EtOAc--hexane. Amorphous yellow solid, 323 mg, 86%, ^1^H NMR (DMSO-*d*~6~, 500 MHz): δ 13.27 (s, 1H), 7.85 (bs, 12H), 7.79 (bs, 2H), 7.44 (bs, 2H), 7.33 (bs, 1H), 7.07--7.03 (m, 3H); ^13^C NMR (DMSO-*d*~6~, 120 MHz): δ 158.9, 151.2, 143.2, 133.7, 128.6, 127.3, 126.4, 125.0, 121.2, 114.2, 98.7, 55.0; HRMS-ESI^+^ (*m*/*z*) calcd for C~16~H~15~N~2~O (M + 1H)^+^, 251.1179; found 251.1175.

General Procedure for the Synthesis of 3,5-Diarylpyrazoles from Reaction of Ketones and Aldehyde Hydrazones {#sec4.3}
-----------------------------------------------------------------------------------------------------------

### Method A {#sec4.3.1}

To 1.5 mmol of the ketone (ketone hydrazone in case of reverse method A) in ethanol (10 mL) was added 1.8 mmol of the aldehyde hydrazone (aldehyde in case of reverse method A), followed by 75 μL HCl. The reaction mixture was refluxed for 1 h and then 6.0 mmol DMSO and 0.15 mmol iodine were added. The reaction mixture was refluxed for specified time and monitored by TLC. The reaction mixture was then cooled to room temperature, quenched with 5% aq sodium thiosulfate (30 mL), and extracted with EtOAc (3 × 20 mL). The combined EtOAc extracts were washed with water (1 × 20 mL), dried over anhydrous magnesium sulfate, and concentrated by rotary evaporation. The crude product was purified by column chromatography or crystallization.

### Method B {#sec4.3.2}

To 1.5 mmol of the ketone (ketone hydrazone in case of reverse method B) in ethanol (10 mL) was added 1.8 mmol of the aldehyde hydrazone (aldehyde in case of reverse method B) followed by 75 μL HCl. The reaction mixture was refluxed for 1 h and then 6.0 mmol DMSO was added. The reaction mixture was refluxed for specified time and monitored by TLC. The reaction mixture was then cooled to room temperature, quenched with water (30 mL), and extracted with EtOAc (3 × 20 mL). The combined EtOAc extracts were washed with water (1 × 20 mL), dried over anhydrous magnesium sulfate, concentrated by rotary evaporation, and purified by column chromatography or crystallization.

### Method C {#sec4.3.3}

To 1.5 mmol of the ketone in ethanol (10 mL) added 1.8 mmol of the aldehyde hydrazone, followed by 75 μL HCl and 25 μL H~2~SO~4~. The reaction mixture was refluxed for 1 h and then 6.0 mmol DMSO was added. The reaction mixture was refluxed for specified time and monitored by TLC. The reaction mixture was then cooled to room temperature, quenched with water (30 mL), and extracted with EtOAc (3 × 20 mL). The combined EtOAc extracts were washed with water (1 × 20 mL), dried over anhydrous magnesium sulfate, concentrated by rotary evaporation, and purified by column chromatography or crystallization.

### 3,5-Diphenylpyrazole (**3**) {#sec4.3.4}

Two hundred eighty milligrams, 85% (method A), 267 mg, 81% (method B), 274 mg, and 83% (method C). Identical spectral data to that obtained using phenacyl bromide and benzal hydrazone as described above.

### 3-(4-Hydroxyphenyl)-5-phenyl-1*H*-pyrazole (**16**) {#sec4.3.5}

Purified by column chromatography using a gradient of 30--50% EtOAc--hexane. Amorphous yellow solid, 258 mg, 73% (method A), 244 mg, 69% (method B), 233 mg, 66% (method C). ^1^H NMR (acetone-*d*~6~, 500 MHz): δ 8.8 (bs, 1H), 7.89 (d, *J* = 8.2 Hz, 2H), 7.73 (d, *J* = 8.5 Hz, 2H), 7.43 (appt, *J* = 7.4 Hz, 2H), 7.32 (appt, *J* = 7.4 Hz, 2H), 6.99 (s, 1H), 6.94 (d, *J* = 8.5 Hz, 2H); ^13^C NMR (acetone-*d*~6~, 120 MHz): δ 159.3, 134.3, 130.5, 129.5, 128.6, 127.1, 124.9, 117.5, 100.5; HRMS-ESI^+^ (*m*/*z*) calcd for C~15~H~13~N~2~O (M + 1H)^+^, 237.1022; found 237.1021.

### 4-(5-(3-Methoxyphenyl)-1*H*-pyrazol-3-yl)phenol (**17**) {#sec4.3.6}

Purified by column chromatography using a gradient of 50% EtOAc--hexane. Amorphous yellow solid, 283 mg, 71% (method A). ^1^H NMR (acetone-*d*~6~, 500 MHz): δ 8.8 (bs, 1H), 7.71 (d, *J* = 8.3 Hz, 2H), 7.45 (s, 1H), 7.44 (d, *J* = 8.2 Hz, 1H), 7.31 (appt, *J* = 8.0 Hz, 1H), 6.99 (s, 1H), 6.91 (d, *J* = 8.6 Hz, 2H), 6.88 (d, *J* = 8.3 Hz, 1H), 3.88 (s, 3H); ^13^C NMR (acetone-*d*~6~, 120 MHz): δ 160.0, 159.4, 131.6, 128.6, 119.6, 117.5, 115.2, 112.4, 100.7, 56.5; HRMS-ESI^+^ (*m*/*z*) calcd for C~16~H~15~N~2~O~2~ (M + 1H)^+^, 267.1128; found 267.1127.

### 3-(3-(4-Hydroxyphenyl)-1*H*-pyrazol-5-yl)phenol (**18**) {#sec4.3.7}

Purified by column chromatography using a gradient of 50--80% EtOAc--hexane. Amorphous yellow solid, 268 mg, 71% (method A), 242 mg, 64% (method C). ^1^H NMR (acetone-*d*~6~, 500 MHz): δ 8.61 (bs, 1H), 7.71 (d, *J* = 8.5 Hz, 2H), 7.34--7.38 (m, 2H), 7.25 (appt, *J* = 8.0 Hz), 6.92--6.93 (m, 3H), 6.83 (dd, *J* = 7.9, 2.5 Hz, 1H); ^13^C NMR (acetone-*d*~6~, 120 MHz): δ 159.5, 159.3, 135.5, 131.6, 128.6, 125.0, 118.6, 117.4, 116.6, 114.1, 100.5; HRMS-ESI^+^ (*m*/*z*) calcd for C~15~H~13~N~2~O~2~ (M + 1H)^+^, 253.0971; found 253.0970.

### 4-(5-Phenyl-1*H*-pyrazol-3-yl)aniline (**19**) {#sec4.3.8}

Purified by column chromatography using a gradient of 60--80% EtOAc--hexane. Two hundred eleven milligrams, 60% (method B), 215 mg, 61% (method C). ^1^H NMR (DMSO-*d*~6~, 500 MHz): δ 12.97 (bs, 1H), 7.83 (d, *J* = 6.3 Hz, 2H), 4.49 (d, *J* = 6.6 Hz, 2H), 7.43 (appt, *J* = 7.1 Hz, 2H), 7.31 (appt, *J* = 7.1 Hz, 1H), 6.91 (s, 1H), 6.64 (d, *J* = 8.5 Hz, 2H); ^13^C NMR (DMSO-*d*~6~, 120 MHz): δ 148.7, 128.6, 127.2, 126.0, 124.9, 113.8, 97.4; HRMS-ESI^+^ (*m*/*z*) calcd for C~15~H~14~N~3~ (M + 1H)^+^, 236.1182; found 236.1182.

### 3-(3,4-Dimethoxyphenyl)-5-phenyl-1*H*-pyrazole (**20**) {#sec4.3.9}

Purified by column chromatography using 40% EtOAc--hexane. Amorphous yellow solid, 323 mg, 77% (method A), 315 mg, 75% (method B), 336 mg, 80% (reverse B). ^1^H NMR (DMSO-*d*~6~, 500 MHz): δ 13.2 (bs, 1H), 7.86 (d, *J* = 7.4 Hz, 2H), 7.45--7.47 (m, 3H), 7.39 (d, *J* = 8.2 Hz, 1H), 7.34 (appt, *J* = 7.4 Hz, 1H), 7.14 (s, 1H), 7.02 (d, *J* = 8.2 Hz, 1H); 3.86 (s, 3H), 3.80 (s, 3H); ^13^C NMR (DMSO-*d*~6~, 120 MHz): δ 148.9, 148.6, 128.7, 127.6, 125.0, 117.5, 111.9, 108.9, 99.0, 55.5; HRMS-ESI^+^ (*m*/*z*) calcd for C~17~H~17~N~2~O~2~ (M + 1H)^+^, 281.1285; found 281.1284.

### 3-(3,4-Dimethoxyphenyl)-5-(4-(trifluoromethyl)phenyl)-1*H*-pyrazole (**21**) {#sec4.3.10}

Purified by column chromatography using 30% EtOAc--hexane. Amorphous orange solid, 449 mg, 86% (method A), 444 mg, 85% (method B). ^1^H NMR (DMSO-*d*~6~, 500 MHz): δ 13.43 (s, 1H), 8.07 (d, *J* = 5.8 Hz, 2H), 7.79 (bs, 2H), 7.45 (s, 1H), 7.38 (d, *J* = 7.7 Hz, 1H), 7.27 (s, 1H), 7.04 (d, *J* = 7.4 Hz, 1H); 3.86 (s, 3H), 3.79 (s, 3H); ^13^C NMR (DMSO-*d*~6~, 120 MHz): δ 149.0, 144.0, 137.7, 125.5, 117.6, 112.0, 109.0, 99.6, 55.5; ^19^F NMR (DMSO-*d*~6~, 470 MHz): δ 61.19; HRMS-ESI^+^ (*m*/*z*) calcd for C~18~H~16~F~3~N~2~O~2~ (M + 1H)^+^, 349.1158; found 349.1155.

### 5-(4-Bromophenyl)-3-phenyl-1*H*-pyrazole (**22**) {#sec4.3.11}

Crystallized from 80% aqueous ethanol. Pale yellow solid, 404 mg, 90% (method A), 386 mg, 86% (method B), 413 mg, 92% (reverse A and B). Mp 212--213 °C. ^1^H NMR (DMSO-*d*~6~, 500 MHz): δ 13.42 (bs, 1H), 7.84 (d, *J* = 7.9 Hz, 2H), 7.82 (d, *J* = 8.5 Hz, 2H), 7.65 (d, *J* = 8.5 Hz, 2H), 7.47 (appt, *J* = 7.7 Hz, 2H), 7.34 (appt, *J* = 7.4 Hz, 1H), 7.23 (s, 1H); ^13^C NMR (DMSO-*d*~6~, 120 MHz): δ 132.2, 129.4, 128.4, 127.6, 125.6, 121.2, 100.4; HRMS-ESI^+^ (*m*/*z*) calcd for C~15~H~12~BrN~2~ (M + 1H)^+^, 301.0158; found 301.0158.

### 3-(3-(4-Bromophenyl)-1*H*-pyrazol-5-yl)phenol (**23**) {#sec4.3.12}

Crystallized from 80% aqueous ethanol. Four hundred twenty-five milligrams, 90% (method A), 402 mg, 85% (method B), 435 mg, 92% (reverse A), 425 mg, 90% (reverse B). Mp 220--221 °C. ^1^H NMR (acetone-*d*~6~, 500 MHz): δ 12.61 (s, 1H), 8.57 (s, 1H), 7.84 (d, *J* = 8.0 Hz, 2H), 7.60 (d, *J* = 8.3 Hz, 2H), 7.34 (s, 1H), 7.33 (s, 1H), 7.28 (appt, *J* = 7.3 Hz, 1H), 7.09 (s, 1H), 6.85 (d, *J* = 7.3 Hz, 1H); ^13^C NMR (acetone-*d*~6~, 120 MHz): δ 157.9, 131.7, 130.0, 127.2, 121.0, 116.7, 115.1, 112.3, 99.8; HRMS-ESI^+^ (*m*/*z*) calcd for C~15~H~12~BrN~2~O (M + 1H)^+^, 315.0128; found 315.0126.

### 5-Phenyl-3-(thiophen-2-yl)-1*H*-pyrazole (**24**) {#sec4.3.13}

Purified by column chromatography using a gradient of 10--20% EtOAc--hexane. Amorphous yellow solid, 264 mg, 78% (method A), 272 mg, 80% (method B). ^1^H NMR (acetone-*d*~6~, 500 MHz): δ 12.56 (s, 1H), 7.85 (d, *J* = 7.4 Hz, 2H), 7.44--7.47 (m, 3H), 7.41 (d, *J* = 4.9 Hz, 1H), 7.36 (appt, *J* = 7.1 Hz, 1H), 7.10 (dd, *J* = 4.9, 3.6 Hz, 1H), 6.99 (s, 1H); ^13^C NMR (acetone-*d*~6~, 120 MHz): δ 128.9, 128.1, 127.5, 125.3, 124.6, 123.8, 99.5; HRMS-ESI^+^ (*m*/*z*) calcd for C~13~H~11~N~2~S (M + 1H)^+^, 227.0638; found 227.0637.

### 5-(3-Methoxyphenyl)-3-(thiophen-2-yl)-1*H*-pyrazole (**25**) {#sec4.3.14}

Purified by column chromatography using 30% EtOAc--hexane. Amorphous yellow solid, 285 mg, 74% (method A), 304 mg, 79% (method B). ^1^H NMR (acetone-*d*~6~, 500 MHz): δ 12.61 (s, 1H), 7.48 (d, *J* = 3.7 Hz, 1H), 7.42--7.45 (m, 3H), 7.38 (appt, *J* = 7.9 Hz, 1H), 7.12 (dd, *J* = 4.9, 3.6 Hz, 1H), 7.02 (s, 1H), 6.95 (dd, *J* = 6.8, 1.6 Hz, 1H), 3.88 (s, 3H); ^13^C NMR (acetone-*d*~6~, 120 MHz): δ 162.1, 131.8, 129.3, 126.5, 125.6, 119.5, 115.7, 112.4, 101.6, 56.6; HRMS-ESI^+^ (*m*/*z*) calcd for C~14~H~12~N~2~OS (M + 1H)^+^, 257.0743; found 257.0743.

### 3-(3,4-Dimethoxyphenyl)-5-(3-methoxyphenyl)-1*H*-pyrazole (**33**) {#sec4.3.15}

Purified by column chromatography using 50% EtOAc--hexane. Amorphous yellow solid, 377 mg, 81% (reverse A), 386 mg, 83% (reverse B). ^1^H NMR (acetone-*d*~6~, 500 MHz): δ 12.64 (bs, 1H), 7.50 (s, 1H), 7.48 (s, 1H), 7.45 (d, *J* = 7.8 Hz, 1H), 7.39 (appt, 1H, *J* = 7.8 Hz, 1H), 7.08 (s, 1H), 6.97 (d, *J* = 8.1 Hz), 6.89 (dd, *J* = 8.1, 2.2, 1H), 3.83 (s, 3H), 3.81 (s, 6H); ^13^C NMR (acetone-*d*~6~, 120 MHz): δ 162.0, 151.5, 151.3, 135.4, 131.6, 126.4, 119.8, 119.6, 115.2, 113.8, 112.4, 111.0, 101.0, 57.0, 56.5; HRMS-ESI^+^ (*m*/*z*) calcd for C~18~H~19~N~2~O~3~ (M + 1H)^+^, 311.1390; found 311.1390.

### 3-(3-(3,4-Dimethoxyphenyl)-1*H*-pyrazol-5-yl)phenol (**34**) {#sec4.3.16}

Purified by column chromatography using 60% EtOAc--hexane. Amorphous yellow solid, 360 mg, 81% (reverse A), 373 mg, 84% (reverse B). ^1^H NMR (acetone-*d*~6~, 500 MHz): δ 9.85 (bs, 1H), 7.48 (d, *J* = 1.7 Hz, 1H), 7.37--7.40 (m, 2H), 7.34 (d, *J* = 7.6 Hz, 1H), 7.25 (appt, *J* = 7.8 Hz, 1H), 7.00 (d, *J* = 7.2 Hz, 1H), 6.99 (s, 1H), 6.82 (dd, *J* = 7.6, 1.7 Hz), 3.86 (s, 3H), 3.82 (s, 3H); ^13^C NMR (acetone-*d*~6~, 120 MHz): δ 158.1, 149.4, 149.1, 130.2, 118.0, 116.6, 115.2, 112.4, 109.4, 99.6, 56.0; HRMS-ESI^+^ (*m*/*z*) calcd for C~17~H~17~N~2~O~3~ (M + 1H)^+^, 297.1234; found 297.1233.

### 3-(4-Bromophenyl)-5-(4-(trifluoromethyl)phenyl)-1*H*-pyrazole (**35**) {#sec4.3.17}

Crystallized from 80% aqueous ethanol. Five hundred seven milligrams, 92% (reverse A), 496 mg, 90% (reverse B). Mp 227--229 °C. ^1^H NMR (DMSO-*d*~6~, 500 MHz): δ 8.06 (d, *J* = 7.9 Hz, 1H), 7.81 (d, *J* = 8.5 Hz, 4H), 7.67 (d, *J* = 8.4 Hz, 2H), 7.37 (s, 1H); ^13^C NMR (DMSO-*d*~6~, 120 MHz): δ 131.7, 127.8 (q, *J* = 31.2 Hz), 127.0, 125.7, 125.5, 125.3, 123.1, 121.0, 100.8; ^19^F NMR (DMSO-*d*~6~, 470 MHz): δ 61.28; HRMS-ESI^+^ (*m*/*z*) calcd for C~16~H~11~BrF~3~N~2~ (M + 1H)^+^, 367.0052; found 367.0051.

### 3-(4-Bromophenyl)-5-(3-methoxyphenyl)-1*H*-pyrazole (**36**) {#sec4.3.18}

Crystallized from 80% aqueous ethanol. Four hundred and forty-four milligrams, 90% (reverse A and B). Mp 169--171 °C. ^1^H NMR (DMSO-*d*~6~, 500 MHz): δ 7.82 (d, *J* = 8.3 Hz, 2H), 7.65 (d, *J* = 8.3 Hz, 2H), 7.41--7.43 (m, 2H), 7.38 (appt, *J* = 8.1 Hz, 1H), 7.26 (s, 1H), 6.93 (d, *J* = 8.1 Hz, 1H), 3.82 (s, 3H); ^13^C NMR (DMSO-*d*~6~, 120 MHz): δ 159.6, 131.6, 129.9, 127.0, 120.6, 117.4, 113.5, 110.4, 100.0, 55.1; HRMS-ESI^+^ (*m*/*z*) calcd for C~16~H~14~BrN~2~O (M + 1H)^+^, 329.0284; found 329.0284.

### 5-(3-Methoxyphenyl)-3-phenyl-1*H*-pyrazole (**37**) {#sec4.3.19}

Purified by column chromatography using 30% EtOAc--hexane. Amorphous yellow solid, 308 mg, 82% (method A), 338 mg, 90% (method B). ^1^H NMR (acetone-*d*~6~, 500 MHz, 120 °C): δ 12.75 (1H, s), 7.89 (s, 2H), 7.46 (s, 4H), 7.36 (s, 2H), 7.13 (s, 1H), 6.92 (s, 1H), 3.86 (s, 3H); ^13^C NMR (DMSO-*d*~6~, 120 MHz, 120 °C): δ 159.3, 129.0, 127.9, 126.9, 124.7, 117.2, 113.0, 110.5, 99.2, 54.8; HRMS-ESI^+^ (*m*/*z*) calcd for C~16~H~15~N~2~O (M + 1H)^+^, 251.1179; found 251.1178.

### 3-(3-Phenyl-1*H*-pyrazol-5-yl)phenol (**38**) {#sec4.3.20}

Purified by column chromatography using 40% EtOAc--hexane. Amorphous yellow solid, 248 mg, 70% (method A), 262 mg, 74% ([Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}, entry 5). ^1^H NMR (acetone-*d*~6~, 500 MHz): δ 12.48 (s, 1H), 8.46 (s, 1H), 7.88 (d, *J* = 7.4 Hz, 2H), 7.44 (appt, *J* = 7.4 Hz, 2H), 7.32--7.36 (m, 3H), 7.27 (appt, *J* = 7.7 Hz, 1H), 7.05 (s, 1H), 8.83 (dd, *J* = 8.3, 1.3 Hz, 1H); ^13^C NMR (acetone-*d*~6~, 120 MHz): δ 159.7, 131.7, 130.6, 129.6, 127.2, 118.6, 116.7, 114.1, 101.4; HRMS-ESI^+^ (*m*/*z*) calcd for C~15~H~13~N~2~O (M + 1H)^+^, 237.1022; found 237.1022.

###### Synthesis of 3,5-Diarylpyrazoles Using 2-Phenoxyacetophenone

![](ao-2018-02304m_0008){#fx5}

Method A: Ketone added to 1.2 equiv of the aldehyde hydrazone in ethanol followed by cat. aq HCl. Reflux for 1 h and add 4 equiv DMSO and 10 mol % I~2~.

Method B: Same as method A, except no I~2~ added.

Isolated yield.

Cat. HCl, EtOH, reflux 16 h.

### 3-Phenyl-5-(4-(trifluoromethyl)phenyl)-1*H*-pyrazole (**39**) {#sec4.3.21}

Purified by column chromatography using 15% EtOAc--hexane. Amorphous yellow solid, 268 mg, 62% (method A), 290 mg, 67% (method B). ^1^H NMR (acetone-*d*~6~, 500 MHz): δ 12.77 (1H, s), 8.12 (d, *J* = 8.0 Hz, 2H), 7.87 (d, *J* = 7.4 Hz, 2H), 7.78 (d, *J* = 8.0 Hz), 7.48 (appt, *J* = 7.4 Hz, 2H), 7.38 (appt, *J* = 7.4 Hz, 1H), 7.26 (s, 1H); ^13^C NMR (acetone-*d*~6~, 120 MHz): δ 128.9, 128.2, 125.7, 125.6, 125.3, 100.3; ^19^F NMR (acetone-*d*~6~, 470 MHz): δ 63.24; HRMS-ESI^+^ (*m*/*z*) calcd for C~16~H~12~F~3~N~2~ (M + 1H)^+^, 289.0947; found 289.0946.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.8b02304](http://pubs.acs.org/doi/abs/10.1021/acsomega.8b02304).Crystallographic data ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b02304/suppl_file/ao8b02304_si_001.cif))Copies of NMR spectra for all pyrazoles, copies of NMR spectra of pyrazole **26**, and X-ray crystal structure of 3,5-diphenylpyrazole **3** ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b02304/suppl_file/ao8b02304_si_002.pdf))
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